| Primary |
| Epilepsy |
29.3% |
| Product Used For Unknown Indication |
18.5% |
| Bipolar Disorder |
13.5% |
| Convulsion |
9.2% |
| Drug Use For Unknown Indication |
5.8% |
| Depression |
5.7% |
| Schizophrenia |
2.5% |
| Grand Mal Convulsion |
2.1% |
| Partial Seizures |
1.7% |
| Hypertension |
1.6% |
| Prophylaxis Of Neural Tube Defect |
1.4% |
| Bipolar I Disorder |
1.3% |
| Major Depression |
1.1% |
| Affective Disorder |
1.1% |
| Bipolar Ii Disorder |
1.0% |
| Insomnia |
0.9% |
| Complex Partial Seizures |
0.9% |
| Contraception |
0.8% |
| Drug Exposure During Pregnancy |
0.7% |
| Mood Swings |
0.7% |
|
| Product Substitution Issue |
13.4% |
| Drug Exposure During Pregnancy |
9.5% |
| Rash |
9.5% |
| Convulsion |
9.2% |
| Therapeutic Response Unexpected With Drug Substitution |
6.8% |
| Vomiting |
6.6% |
| Drug Ineffective |
5.9% |
| Maternal Drugs Affecting Foetus |
4.8% |
| Stevens-johnson Syndrome |
3.9% |
| Toxicity To Various Agents |
3.2% |
| Tremor |
3.1% |
| Vision Blurred |
3.1% |
| Maternal Exposure During Pregnancy |
2.9% |
| Somnolence |
2.8% |
| Completed Suicide |
2.6% |
| Epilepsy |
2.6% |
| Ventricular Septal Defect |
2.6% |
| Product Quality Issue |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
26.2% |
| Epilepsy |
20.0% |
| Drug Use For Unknown Indication |
16.1% |
| Convulsion |
6.7% |
| Bipolar Disorder |
6.5% |
| Depression |
5.4% |
| Infantile Spasms |
2.5% |
| Schizophrenia |
2.0% |
| Bipolar Ii Disorder |
1.6% |
| Partial Seizures |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Drug Exposure During Pregnancy |
1.3% |
| Complex Partial Seizures |
1.3% |
| Intentional Overdose |
1.1% |
| Psychotic Disorder |
1.1% |
| Insomnia |
1.1% |
| Bipolar I Disorder |
1.1% |
| Major Depression |
1.1% |
| Status Epilepticus |
1.0% |
| Hypertension |
1.0% |
|
| Completed Suicide |
21.2% |
| Toxicity To Various Agents |
8.4% |
| Death |
6.1% |
| Respiratory Arrest |
5.5% |
| Vomiting |
5.5% |
| Convulsion |
5.1% |
| Drug Exposure During Pregnancy |
5.0% |
| Drug Ineffective |
4.6% |
| Rash |
4.5% |
| Stevens-johnson Syndrome |
3.9% |
| Poisoning |
3.7% |
| Somnolence |
3.3% |
| Suicide Attempt |
3.3% |
| Maternal Exposure During Pregnancy |
3.2% |
| Drug Toxicity |
3.0% |
| Tremor |
3.0% |
| Weight Decreased |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.8% |
| Cardio-respiratory Arrest |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
|
| Concomitant |
| Epilepsy |
22.2% |
| Product Used For Unknown Indication |
21.7% |
| Depression |
8.7% |
| Drug Use For Unknown Indication |
8.4% |
| Bipolar Disorder |
7.3% |
| Convulsion |
6.3% |
| Schizophrenia |
3.1% |
| Anxiety |
3.1% |
| Hypertension |
2.9% |
| Pain |
2.5% |
| Insomnia |
1.9% |
| Affective Disorder |
1.8% |
| Multiple Sclerosis |
1.8% |
| Psychotic Disorder |
1.5% |
| Hiv Infection |
1.4% |
| Rheumatoid Arthritis |
1.2% |
| Sleep Disorder |
1.2% |
| Bipolar I Disorder |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hypothyroidism |
1.0% |
|
| Convulsion |
11.0% |
| Vomiting |
10.6% |
| Epilepsy |
8.9% |
| Weight Increased |
7.9% |
| Drug Ineffective |
5.9% |
| Tremor |
5.8% |
| Somnolence |
5.7% |
| Pregnancy |
4.1% |
| Weight Decreased |
4.1% |
| Status Epilepticus |
3.9% |
| White Blood Cell Count Increased |
3.7% |
| Death |
3.5% |
| Nausea |
3.5% |
| Suicide Attempt |
3.5% |
| Grand Mal Convulsion |
3.2% |
| Rash |
3.2% |
| White Blood Cell Count Decreased |
3.1% |
| Urinary Tract Infection |
3.0% |
| Vision Blurred |
3.0% |
| Suicidal Ideation |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
22.6% |
| Epilepsy |
20.2% |
| Product Used For Unknown Indication |
10.5% |
| Bipolar Disorder |
10.0% |
| Convulsion |
8.9% |
| Convulsion Prophylaxis |
3.8% |
| Psychotic Disorder |
3.8% |
| Contraception |
2.7% |
| Depression |
2.7% |
| Myoclonic Epilepsy |
2.5% |
| Bronchitis |
1.6% |
| Partial Seizures |
1.6% |
| Obesity |
1.5% |
| Back Pain |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Mania |
1.1% |
| Traumatic Brain Injury |
1.1% |
| Seasonal Allergy |
1.0% |
| Complex Partial Seizures |
0.8% |
| Eczema |
0.8% |
|
| Drug Interaction |
18.1% |
| Epilepsy |
9.4% |
| Hallucination |
7.2% |
| Tremor |
6.5% |
| Vomiting |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Malabsorption |
5.1% |
| Neuroleptic Malignant Syndrome |
5.1% |
| Sweat Gland Disorder |
4.3% |
| Tachycardia |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
| Diplopia |
2.9% |
| Histiocytosis Haematophagic |
2.9% |
| Mobility Decreased |
2.9% |
| Pyrexia |
2.9% |
| Intention Tremor |
2.2% |
| Prescribed Overdose |
2.2% |
| Pruritus |
2.2% |
| Sleep Disorder |
2.2% |
| Stevens-johnson Syndrome |
2.2% |
|
